Pedersen M, Rönnstrand L, Sun J
Experimental Clinical Chemistry, Department of Laboratory Medicine, Malmö University Hospital, Lund University, SE-205 02 Malmö, Sweden.
Cell Signal. 2009 Mar;21(3):413-8. doi: 10.1016/j.cellsig.2008.11.008. Epub 2008 Nov 17.
Activating mutations of codon 816 of the Kit gene have been implicated in malignant cell growth of acute myeloid leukemia (AML), systemic mastocytosis and germ cell tumors. Substitution of aspartic acid with valine (D816V) renders the receptor independent of ligand for activation and signaling. Wild-type c-Kit is a tyrosine kinase receptor that requires its ligand, stem cell factor (SCF), for activation. Several isoforms of c-Kit exist as a result of alternative mRNA splicing, of which two are characterized by the presence or absence of four amino acids (GNNK- and GNNK+, respectively) in the extracellular domain. The two isoforms show differences in signal transduction and biological activities and the shorter isoform seems to be highly expressed than the longer isoform in human malignancies. In this study we analysed the signal transduction downstream of the oncogenic c-Kit mutant D816V in an isoform specific context, using the hematopoietic cell line Ba/F3 stably transfected with the different versions of isoform and mutant receptor. Our data show that in contrast to the differences shown in the activation of wild-type c-Kit isoforms, both isoforms of c-Kit/D816V are constitutively phosphorylated to the same extent. By the use of Western blot analysis we investigated the activation of different signaling proteins and found that both D816V/GNNK- and D816V/GNNK+ constitutively phosphorylated Gab2, Shc, SHP-2 and Cbl to almost the same extent as c-Kit/GNNK-. In addition, both isoforms of c-Kit/D816V induced SCF-independent cell survival and proliferation equally well. This is in contrast to wild-type c-Kit, where c-Kit/GNNK- induced better cell survival and stronger proliferation than c-Kit/GNNK+, and both required stimulation with SCF. Taken together, these findings reveal that the differences in downstream signal transduction and biological responses between the two GNNK isoforms are eliminated by the D816V mutant.
Kit基因第816密码子的激活突变与急性髓系白血病(AML)、系统性肥大细胞增多症和生殖细胞肿瘤的恶性细胞生长有关。天冬氨酸被缬氨酸取代(D816V)使受体在激活和信号传导时不依赖配体。野生型c-Kit是一种酪氨酸激酶受体,其激活需要配体干细胞因子(SCF)。由于可变mRNA剪接,存在几种c-Kit同工型,其中两种的特征是细胞外结构域中存在或不存在四个氨基酸(分别为GNNK-和GNNK+)。这两种同工型在信号转导和生物学活性上表现出差异,在人类恶性肿瘤中,较短的同工型似乎比较长的同工型表达更高。在本研究中,我们使用稳定转染了不同版本同工型和突变受体的造血细胞系Ba/F3,在同工型特异性背景下分析了致癌c-Kit突变体D816V的下游信号转导。我们的数据表明,与野生型c-Kit同工型激活中显示的差异相反,c-Kit/D816V的两种同工型都以相同程度组成性磷酸化。通过蛋白质免疫印迹分析,我们研究了不同信号蛋白的激活,发现D816V/GNNK-和D816V/GNNK+组成性磷酸化Gab2、Shc、SHP-2和Cbl的程度几乎与c-Kit/GNNK-相同。此外,c-Kit/D816V的两种同工型在诱导不依赖SCF的细胞存活和增殖方面同样良好。这与野生型c-Kit相反,在野生型c-Kit中,c-Kit/GNNK-比c-Kit/GNNK+诱导更好的细胞存活和更强的增殖,并且两者都需要SCF刺激。综上所述,这些发现表明D816V突变消除了两种GNNK同工型之间下游信号转导和生物学反应的差异。